A newly developed radiopharmaceutical pair can precisely detect and effectively treat gastric and pancreatic tumors, ...

Graves' disease, an autoimmune thyroid disorder, is being diagnosed more often among young adults. Doctors explain symptoms, ...

Reston, VA (December 4, 2025)--A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a ...

Nuclear medicine is one of the most dynamic branches of modern healthcare, offering detailed functional insights into organs and tissues through the use of radiopharmaceuticals. At Liv Hospital, this ...

Radioiodine (RAI)-refractory thyroid cancer is an uncommon entity, occurring with an estimated incidence of 4-5 cases/year/million people. RAI refractoriness is more frequent in older patients, in ...

Vladimir Putin's recent threats of nuclear weapon use are deeply concerning. A nuclear war would have catastrophic consequences, both short and long-term, including radiation-induced cancers. However, ...

Most follicular cell-derived differentiated thyroid carcinomas are regarded as low-risk neoplasms prompting conservative therapeutic management. Here, we provide consensus recommendations reached by a ...